A phase II safety and efficacy study of amprenavir in combination with zidovudine and lamivudine in HIV-infected patients with limited antiretroviral experience. Amprenavir PROAB2002 Study Team. (Q41707776)
Jump to navigation
Jump to search
scientific article published on December 1999
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A phase II safety and efficacy study of amprenavir in combination with zidovudine and lamivudine in HIV-infected patients with limited antiretroviral experience. Amprenavir PROAB2002 Study Team. |
scientific article published on December 1999 |
Statements
A phase II safety and efficacy study of amprenavir in combination with zidovudine and lamivudine in HIV-infected patients with limited antiretroviral experience. Amprenavir PROAB2002 Study Team (English)
R Haubrich
M Thompson
R Schooley
W Lang
A Stein
D Sereni
M E van der Ende
D Richman
G Pagano
L Kahl
A Fetter
D J Brown